brexpiprazole news

All news on brexpiprazole (also known as Rexulti): plants, production capacities, investments and involved companies.

4 May 2026

Johnson & Johnson: CAPLYTA tops adjunctive MDD antipsychotics in network meta-analysis

Network meta-analysis of 10 trials found an adjunctive atypical antipsychotic superior on MADRS change, response, remission and CGI‑S, with no significant weight gain and favorable tolerability.

Who will be producing brexpiprazole in the future?

Find out with chemXplore

Learn more